Asthma treatment

http://www.healasthma.com – New Indication for SINGULAIR(R) (montelukast sodium) Approved to Prevent Exercise-induced Bronchoconstriction Merck & Co., Inc. Media Amy Rose, – - or Kyra Lindemann, – - or Investor Graeme Bell, – - Merck & Co., Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved a new indication for SINGULAIR(R) (montelukast sodium) to prevent exercise-induced bronchoconstriction (EIB; also known as exercise-induced asthma) in patients aged years and older. SINGULAIR is the first and only oral tablet approved for this use…. . Canada Newswire (French version) (Canada) – Traitement antiasthmatique approuv� par Sant� Canada pour le soulagement des sympt�mes de la rhinite allergique saisonni�re CNW — Les allergies saisonni�res peuvent �tre p�nibles pour certains asthmatiques MONTR�AL, le sept. /CNW/ – Merck Frosst Canada Lt�e a annonc� aujourd’hui que SINGULAIR(R) (mont�lukast sodique), a aussi �t� approuv� pour le soulagement des sympt�mes de la rhinite allergique (RA) saisonni�re, aussi appel� rhume des foins, chez les patients de ans et plus. Un comprim� pratique � prendre une fois par jour et non st�roidien, SINGULAIR(R) est le… . Generic versus prescription ends in a tie Pseudoephedrine, a generic drug sold over the counter, is just as effective in treating hay fever as the prescription drug Singulair, a new study has found, and neither has significant side effects.The study, partly financed by Merck, the maker of Singulair, appears in the issue of The Archives of Otolaryngology – Head and Neck Surgery. Three of its authors are paid consultants to the drug company. Researchers randomly divided healthy adult hay fever sufferers into two groups…. . Sun-Sentinel – DEAR PHARMACIST SUZY COHEN Dear Pharmacist I take Singulair for asthma and it seems to help, though what I notice the most is that my allergies have gotten dramatically better. Is it for both? — N.S., Birmingham, Ala.Dear N.S. There is science behind the fact that drugs such as Singulair help allergies, but they are only FDA-approved for asthma and are often prescribed with inhaled steroids.Drugs such as Singulair, including Accolate and Zyflo, are all known as leukotriene inhibitors (pronounced… CORRECTION A story in the Nov. Star-News incorrectly identified the drug Singulair as a corticosteroid. According to Dr. Patrick Edwards, Singulair is a medication that works to prevent asthma attacks like a steroid, but is not a steroid.Star-News Category Lifestyle Published / / Page D, D Key asthma; illness; health CORRECTION / / CORRECTION A story in the Nov. Star-News incorrectly identified the drug Singulair as a corticosteroid. According to Dr. Patrick Edwards,… business briefs Mylan FDA tentatively OKs generic Singulair CANONSBURG – Mylan Inc. said Friday the Food and Drug Administration has granted tentative approval of its version of Merck and Co.’s multi-billion-selling allergy and asthma drug Singulair.Southpointe-based Mylan is looking to sell a low-cost generic version of the drug, which had U.S. sales of USDThree billion over the months ended . The FDA tentatively approved Mylan’s mg tablet version of the drug, which… . In Brief FDA probing possible link between Singulair, suicide WASHINGTON – The Food and Drug Administration said Thursday it is investigating a possible link between Merck’s best-selling Singulair and suicide. The FDA said it is reviewing a handful of reports involving mood changes, suicidal behavior and suicide in patients who have taken the popular allergy and asthma drug. With sales of USDThree billion last year, Singulair is used by millions of patients in the U.S,… . Chicago Tribune – MERCK & CO. Asthma drug OK for allergy treatment Drugmaker Merck & Co. on Thursday said it had received U.S. approval to market Singulair, already a blockbuster asthma drug, as a treatment for seasonal allergies. The U.S. Food and Drug Administration’s approval gives Singulair a new lease on life as it faces tough competition as an asthma treatment from Advair, sold by British drugmaker GlaxoSmithKline PLC. Singulair, which has been on the market for five years, is the first prescription allergy… New asthma pill approved by FDA The Food and Drug Administration has approved an alternative in asthma care for children Singulair, the first once-a-day pill to help prevent asthma attacks in children as young as .The drug, made by Merck & Co., also is intended for adults.It does not treat asthma attacks — patients must still carry their quick-relief medicines.Instead, Singulair is a non-steroid drug that blocks leukotrines, substances associated with asthma’s inflammatory problems…. FDA approves asthma drug for kids The Food and Drug Administration has approved an alternative in asthma care for children Singulair, the first once-a-day pill to help prevent asthma attacks in children as young as . The drug, manufactured by Merck & Co., also is intended for adults. It does not treat asthma attacks — patients must still carry their quick-relief medicines. Approval was announced Monday.Singulair is a non-steroid drug that blocks leukotrines, substances associated with… –